 persons are elderly, frail, and are living in vulnerable socio-economic circumstances with a low quality of
life.131,132 It is therefore essential that cardiovascular risk
factor management in these people should be individualised, tailored, and should be part of a shared decision
making process, taking life expectancy, diabetes related
complications and co-morbidities, expected beneÔ¨Åt,
treatment burden, drug interactions, and undesirable
treatment effects into account. This care